Celgene Corp (CELG) 138.22 $CELG
Final Glance: Biotechnology companies
AP - 36 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma
PR Newswire - Tue Apr 08, 12:20PM CDT
On Monday, April 07, 2014, the NASDAQ Composite ended at 4,079.75, down 1.16%, the Dow Jones Industrial Average finished the session 1.02% lower at 16,245.87, and the S&P 500 closed at 1,845.04, down 1.08%. The losses were broad based as nine out of ten sectors finished on a lower note. The S&P 500 Health Care Sector Index finished the day 1.06% lower at 664.68, while the same has gained 3.19% in the previous three months. Investor-Edge has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Celgene Corp. (NASDAQ: CELG), PDL BioPharma Inc. (NASDAQ: PDLI) and Hemispherx Biopharma Inc. (NYSE MKT: HEB). Free technical research on ARNA, CELG, PDLI and HEB can be downloaded upon signing up at:
Midday Glance: Biotechnology companies
AP - Tue Apr 08, 12:16PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Early Glance: Biotechnology companies
AP - Tue Apr 08, 9:43AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Conference Call Schedules, Clinical Trial Studies, Awards and Accolades, Appointments, and Welfare Initiatives - Analyst Notes on Celgene, Johnson & Johnson, Merck, Sanofi, and UnitedHealth
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), Johnson & Johnson (NYSE: JNJ), Merck & Co. Inc. (NYSE: MRK), Sanofi (NYSE: SNY), and UnitedHealth Group, Inc. (NYSE: UNH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Biotech of the Week: Agios Pharmaceuticals
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 07, 7:03PM CDT
As part of their weekly show, Biotech Banter , Fool contributor Brian Orelli and health-care bureau chief Max Macaluso occasionally run a segment highlighting a biotech. This week's honor goes to Agios Pharmaceuticals , which IPOed last year. ...
Tweet of the Week: Big Biotech Dominates Industry Gains
Brian Orelli and Max Macaluso, The Motley Fool - Motley Fool - Mon Apr 07, 4:25PM CDT
This week's tweet comes from Bruce Booth (@LifeSciVC), who points out analysts at Bernstein concluded that just six companies contributed to 77% of the increase in value of the biotech sector over the past three years. There's no doubt that Amgen...
Why Agios Pharmaceuticals Inc. Shares Spiked Higher
Sean Williams, The Motley Fool - Motley Fool - Mon Apr 07, 1:01PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Agios Pharmaceuticals , a clinical-stage...
Celgene Has Returned 10.0% Since SmarTrend Recommendation (CELG)
Comtex SmarTrend(R) - Mon Apr 07, 10:04AM CDT
SmarTrend identified a Downtrend for Celgene (NASDAQ:CELG) on March 7th, 2014 at $155.04. In approximately 1 month, Celgene has returned 10.01% as of today's recent price of $139.52.
Strong Tumor Response Seen From Agios Pharma Cancer Metabolism Drug
at The Street - Mon Apr 07, 7:40AM CDT
Patients with advanced blood cancer respond to treatment with Agios' AG-221, according to study results presented Sunday.
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading
ACCESSWIRE - Sun Apr 06, 11:10PM CDT
GRUBHUB INC. (NYSE: GRUB) - For an in-depth report on GRUBHUB INC. follow: www.BullTrends.com/stockquote/GRUB
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
PR Newswire - Fri Apr 04, 3:15PM CDT
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Skyworks Solutions, Inc. (NDQ: SWKS) as its June 2014 "Stock to Study" and Celgene Corporation (NDQ: CELG) as its June 2014 "Undervalued Stock" for investors' informational and educational use.
Morning Movers in Biotech: Celgene Corporation, Mylan, Inc. and Exelixis, Inc.
George Budwell, The Motley Fool - Motley Fool - Fri Apr 04, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Celgene Corporation , Mylan , and Exelixis . Mylan up on possible takeover of rival Swedish Pharma Shares of drugmaker Mylan are up over 11% in...
Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries
at The Street - Fri Apr 04, 6:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
3 Biggest Biotech Crashes in March
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but the drop in some biotech stocks was simply breathtaking . Celldex Therapeutics , Acceleron , and Newlink Genetics all tumbled more than 25% last month -- far more than the 10% drop in the ...
Final Glance: Biotechnology companies
AP - 36 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma
PR Newswire - Tue Apr 08, 12:20PM CDT
On Monday, April 07, 2014, the NASDAQ Composite ended at 4,079.75, down 1.16%, the Dow Jones Industrial Average finished the session 1.02% lower at 16,245.87, and the S&P 500 closed at 1,845.04, down 1.08%. The losses were broad based as nine out of ten sectors finished on a lower note. The S&P 500 Health Care Sector Index finished the day 1.06% lower at 664.68, while the same has gained 3.19% in the previous three months. Investor-Edge has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Celgene Corp. (NASDAQ: CELG), PDL BioPharma Inc. (NASDAQ: PDLI) and Hemispherx Biopharma Inc. (NYSE MKT: HEB). Free technical research on ARNA, CELG, PDLI and HEB can be downloaded upon signing up at:
Midday Glance: Biotechnology companies
AP - Tue Apr 08, 12:16PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Early Glance: Biotechnology companies
AP - Tue Apr 08, 9:43AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Conference Call Schedules, Clinical Trial Studies, Awards and Accolades, Appointments, and Welfare Initiatives - Analyst Notes on Celgene, Johnson & Johnson, Merck, Sanofi, and UnitedHealth
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), Johnson & Johnson (NYSE: JNJ), Merck & Co. Inc. (NYSE: MRK), Sanofi (NYSE: SNY), and UnitedHealth Group, Inc. (NYSE: UNH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Biotech of the Week: Agios Pharmaceuticals
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 07, 7:03PM CDT
As part of their weekly show, Biotech Banter , Fool contributor Brian Orelli and health-care bureau chief Max Macaluso occasionally run a segment highlighting a biotech. This week's honor goes to Agios Pharmaceuticals , which IPOed last year. ...
Tweet of the Week: Big Biotech Dominates Industry Gains
Brian Orelli and Max Macaluso, The Motley Fool - Motley Fool - Mon Apr 07, 4:25PM CDT
This week's tweet comes from Bruce Booth (@LifeSciVC), who points out analysts at Bernstein concluded that just six companies contributed to 77% of the increase in value of the biotech sector over the past three years. There's no doubt that Amgen...
Why Agios Pharmaceuticals Inc. Shares Spiked Higher
Sean Williams, The Motley Fool - Motley Fool - Mon Apr 07, 1:01PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Agios Pharmaceuticals , a clinical-stage...
Celgene Has Returned 10.0% Since SmarTrend Recommendation (CELG)
Comtex SmarTrend(R) - Mon Apr 07, 10:04AM CDT
SmarTrend identified a Downtrend for Celgene (NASDAQ:CELG) on March 7th, 2014 at $155.04. In approximately 1 month, Celgene has returned 10.01% as of today's recent price of $139.52.
Strong Tumor Response Seen From Agios Pharma Cancer Metabolism Drug
at The Street - Mon Apr 07, 7:40AM CDT
Patients with advanced blood cancer respond to treatment with Agios' AG-221, according to study results presented Sunday.
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading
ACCESSWIRE - Sun Apr 06, 11:10PM CDT
GRUBHUB INC. (NYSE: GRUB) - For an in-depth report on GRUBHUB INC. follow: www.BullTrends.com/stockquote/GRUB
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
PR Newswire - Fri Apr 04, 3:15PM CDT
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Skyworks Solutions, Inc. (NDQ: SWKS) as its June 2014 "Stock to Study" and Celgene Corporation (NDQ: CELG) as its June 2014 "Undervalued Stock" for investors' informational and educational use.
Morning Movers in Biotech: Celgene Corporation, Mylan, Inc. and Exelixis, Inc.
George Budwell, The Motley Fool - Motley Fool - Fri Apr 04, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Celgene Corporation , Mylan , and Exelixis . Mylan up on possible takeover of rival Swedish Pharma Shares of drugmaker Mylan are up over 11% in...
Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries
at The Street - Fri Apr 04, 6:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
3 Biggest Biotech Crashes in March
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but the drop in some biotech stocks was simply breathtaking . Celldex Therapeutics , Acceleron , and Newlink Genetics all tumbled more than 25% last month -- far more than the 10% drop in the ...
